Information about Bard IVC Filter Lawsuits from Lawyers Handling IVC Filter Lawsuits

No-Cost, No-Obligation Bard IVC Filter Lawsuit Review

IVC Filter Lawsuits

IVC Filter Lasers Highlights Focus Attention On Removal Complications

Bard IVC Filter Lawsuits

Surgeons in the past were satisfied when they were unable to retrieve an IVC filter and just left them inside patients

Tuesday, January 4, 2022 - The US Food and Drug Administration has warned doctors that IVC filters can be the source of morbidities in patients and should be considered only as a last resort when all forms of chemical blood thinners have failed. The FDA also warns that the filter should be removed at the earliest possible opportunity as chances are the longer you wait, the more the device will become encapsulated in scar tissue and require invasive surgery to remove. Bard has sold their line of IVC filters to doctors without warning them of the life-threatening complications that could occur if IVC removal was unsuccessful, including that the device can break into pieces that are free to travel with the flow of blood and lacerate and become embedded in the lungs or heart. Bard IVC filter lawsuits attempt to hold the company accountable for failing to warn patients about the complications of IVC filter removal. Neither did Bard advise physicians of the procedures to use to remove the filter. AhaJournals.com writes, "Although chronically implanted inferior vena cava filters may result in filter-related morbidity, there is currently no routine option for removing such filters when they become firmly embedded along the vena cava endothelium." IVC filters left in place permanently can continue to trap blood clots and may themselves become a source of clots. Surgeons today have access to laser IVC removal technology to help them carefully excise the IVC tissue within which the filter has become embedded and facilitate its removal. A recent study of 100 IVC patients with failed IVC removal attempts showed a 98 percent success rate in excising the filter from the scar tissue and successfully retrieving it. Hello.com describes the current IVC filter retrieval climate before the laser. "To date, there have been limited options for the successful removal of chronically embedded IVC filters, as they can be difficult to retrieve due to potential complications associated with the complex procedure," Bram Zuckerman, MD, director of the Office of Cardiovascular Devices in the FDA's Center for Devices and Radiological Health, said in the release"

Laser-assisted IVC filter removal has only been FDA-approved since December 21, 2021, but it is already being hailed as a breakthrough medical device by the US Food and Drug Administration (FDA). Thousands of people are implanted with IVC filters due to having the condition where excessive blood clots threaten pulmonary thrombosis, stroke, or heart attack, and have sought the guidance of an IVC filter lawyer. Most doctors are untrained in removing the filter after a short time as is recommended by the FDA. The IVC filter can tilt, break, or fracture during removal if the surgeon is not careful and pieces can migrate and impale themselves on vital organs and cause death. More than 250,000 patients had the filter implanted in them in 2012 alone and that number doubles every few years according to the Journal. The Journal cites that the rising IVC filter use has increased IVC filter complications and filter-related deaths. "Rising filter use has led to an increase in filter-related morbidity and recognition of potential complications from indwelling filters."

More Recent IVC Filter Lawsuit News:

No-Cost, No-Obligation Bard IVC Filter Lawsuit Case Review for Persons or Families of Persons Who Suffered from Organ Damage, Severe Bleeding, Stroke, or Death

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.